Home » Topics » Regulatory » Patents

Patents
RSS

Bayer Healthcare divulges TNKS1/TNKS2 inhibitors for cancer

Nov. 23, 2016

Chiesi Farmaceutici reports compounds for asthma and COPD

Nov. 23, 2016

AstraZeneca describes LTC4 synthase inhibitors

Nov. 23, 2016

University of Colorado patent reveals beta-lactam antibiotic sensitizers

Nov. 23, 2016

Rgenix patents SLC6A8 inhibitors for cancer

Nov. 23, 2016

Roche presents HBsAg and HBV DNA production inhibitors

Nov. 22, 2016

Actelion Pharmaceuticals describes TPHI1 inhibitors

Nov. 22, 2016

Janssen R&D Ireland discloses agents for RSV infection

Nov. 22, 2016

Janssen Pharmaceutica patents TARPgamma8 inhibitors

Nov. 22, 2016

Laboratorios del Dr. Esteve presents dual sigma1 and mu-opioid receptor ligands

Nov. 21, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...